Hearing Loss News and Research RSS Feed - Hearing Loss News and Research

Hearing loss, impairment or deafness may be of two major types: one that develops some time in life, one that a baby is born with – or congenital deafness. Most commonly, hearing loss is seen with age or is caused by exposure to loud noises.
Ebola survivors face long-term adverse health effects: Study

Ebola survivors face long-term adverse health effects: Study

Ebola survivors experienced negative health effects that persisted more than two years after the 2007-2008 Bundibugyo ebolavirus (BDBV) outbreak in Uganda that claimed 39 lives. These findings are detailed in a paper published online today in Lancet ID. [More]
GenVec, Laboratory of Malaria Immunology and Vaccinology sign research collaboration agreement

GenVec, Laboratory of Malaria Immunology and Vaccinology sign research collaboration agreement

GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. [More]
Public Health Agency of Canada issues statement on measles

Public Health Agency of Canada issues statement on measles

The Public Health Agency of Canada is again reminding Canadians of the importance of ensuring their immunizations are up to date, following the confirmation of additional cases of measles in the Vancouver region. [More]
Loyola otolaryngologist offers tips to identify, treat ear infection in children

Loyola otolaryngologist offers tips to identify, treat ear infection in children

Earaches in babies are not uncommon. But a baby's inability to communicate symptoms can leave most parents feeling helpless. According to the American Academy of Pediatrics, three-fourths of babies will get at least one ear infection before the age of one. [More]
UT Arlington electrical engineer developing low-power integrated circuit for directional hearing aids

UT Arlington electrical engineer developing low-power integrated circuit for directional hearing aids

A University of Texas at Arlington electrical engineering researcher is developing a more efficient, low-power integrated circuit for directional hearing aids that will lead to a better quality of life for hearing impaired people. [More]

Jacoti releases first FDA-registered medical device hearing aid application for smartphones

Jacoti bvba announced today the US release of Jacoti ListenApp, the first FDA registered and CE certified medical device hearing aid application for smartphones. Indicated for mild to moderate hearing loss, ListenApp precisely adjusts the sound of an iOS device to the user's audiogram, transforming the device into a sophisticated, flexible and very affordable hearing instrument with extremely high sound quality. [More]
Regulus' RG-012 receives orphan medicinal product designation in EU for treatment of Alport syndrome

Regulus' RG-012 receives orphan medicinal product designation in EU for treatment of Alport syndrome

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that the European Commission has granted orphan medicinal product designation for RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21") for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy. [More]
GenVec reports record financial results for Q4 and fiscal year 2014

GenVec reports record financial results for Q4 and fiscal year 2014

GenVec, Inc. today reported financial results for the fourth quarter and year ended December 31, 2014. For the year ended December 31, 2014, the company reported a net loss of $2.5 million, or $0.16 per share, compared with a net loss of $10.0 million, or $0.77 per share, for the year ended December 31, 2013. [More]
GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

GenVec, Inc. today announced that it has formed a collaboration with TheraBiologics to develop cancer therapeutics leveraging both GenVec's proprietary gene delivery platform and TheraBiologics' proprietary neural stem cell (NSC) technology. [More]

Nottingham student announced winner in Dragon’s Den style contest dedicated to improve bus journeys for disabled

Transport Minister Baroness Kramer unveiled the winning entry – a vibrating wrist band - in a competition challenging tech-savvy students to improve travel for disabled bus passengers (Friday 13 March). [More]

Babies treated for CMV infection for six months have better developmental outcomes

Babies treated for symptomatic cytomegalovirus (CMV) infection for six months, instead of the standard six weeks, have better hearing and developmental outcomes, according to a new study from the University of Alabama at Birmingham. [More]
SK Telecom unveils consumer-centric smart devices at Mobile World Congress 2015

SK Telecom unveils consumer-centric smart devices at Mobile World Congress 2015

SK Telecom has unveiled a variety of consumer-centric smart devices, or 'Lifeware*', at the Mobile World Congress 2015 with the aim to create opportunities in the global market for the Internet of Things (IoT). [More]
WHO: 1.1 billion young people at risk of hearing loss due to unsafe use of personal audio devices

WHO: 1.1 billion young people at risk of hearing loss due to unsafe use of personal audio devices

Some 1.1 billion teenagers and young adults are at risk of hearing loss due to the unsafe use of personal audio devices, including smartphones, and exposure to damaging levels of sound at noisy entertainment venues such as nightclubs, bars and sporting events, according to WHO. Hearing loss has potentially devastating consequences for physical and mental health, education and employment. [More]
Researchers reveal new understanding of pathobiology behind vestibular schwannoma

Researchers reveal new understanding of pathobiology behind vestibular schwannoma

Researchers from the Eaton-Peabody Laboratories of Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology Program in Speech and Hearing Bioscience and Technology have revealed new understanding of the pathobiology behind a head and neck tumor that may someday lead to new methods of targeted drug therapy. [More]
USF researchers awarded grant to test new drug for age-related hearing loss

USF researchers awarded grant to test new drug for age-related hearing loss

A successful treatment for age-related hearing loss (ARHL) is a step closer to reality, thanks to a group of researchers from the University of South Florida. The research team comprised of faculty and students has been awarded $400,000 by Autifony Therapeutics, Ltd, a company based in the United Kingdom, to test a new drug the company developed for ARHL. [More]
Researchers discover inherited genetic variations associated with treatment-related hearing loss

Researchers discover inherited genetic variations associated with treatment-related hearing loss

St. Jude Children's Research Hospital investigators have discovered inherited genetic variations that are associated with rapid hearing loss in young cancer patients treated with the drug cisplatin. The research appears in the current online issue of the scientific journal Nature Genetics. [More]
Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus. [More]
Musical training in younger years can protect the brain in later life

Musical training in younger years can protect the brain in later life

Scientists have found some of the strongest evidence yet that musical training in younger years can prevent the decay in speech listening skills in later life. [More]
Neuromod Devices, Irish Tinnitus Association announce launch of Tinnitus Awareness Week 2015

Neuromod Devices, Irish Tinnitus Association announce launch of Tinnitus Awareness Week 2015

Saturday 31st of January sees the launch of Tinnitus Awareness Week. This year a public event will take place, hosted by The Neuromod Clinic in conjunction with the Irish Tinnitus Association. This free of charge event will take place at The Hermitage Medical Clinic, Lucan, Dublin at 10.30am on Saturday the 31st January. [More]
MU researcher develops intervention to help older adults gradually adjust to hearing aids

MU researcher develops intervention to help older adults gradually adjust to hearing aids

When individuals wear their hearing aids for the first time, they are flooded with sounds they have not heard in months or years; yet, previous research has shown that not all new sounds are welcomed. Ambient noises such as air conditioners, wind and background conversations can be painful, irritating and difficult to ignore, causing some individuals to stop using their hearing aids right away. [More]
Advertisement
Advertisement